Calcium channel blockers for primary Raynaud's phenomenon-Reference-Cited by-同舟云学术

Calcium channel blockers for primary Raynaud's phenomenon

Published:2016-02-25 Issue: Volume: Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Ennis Holly¹,Hughes Michael²,Anderson Marina E³,Wilkinson Jack⁴,Herrick Ariane L²

Affiliation:

1. University of Edinburgh; Edinburgh Clinical Trials Unit; OPD Building Level 2 Western General Hospital Edinburgh UK EH4 2XU

2. University of Manchester, Manchester Academic Health Science Centre; Centre for Musculoskeletal Research, Institute of Inflammation and Repair; Stopford Building Oxford Road Manchester UK M13 9PT

3. University of Liverpool; Institute of Ageing and Chronic Disease; Liverpool UK

4. University of Manchester, Manchester Academic Health Science Centre; Biostatistics, Institute of Population Health; Clinical Sciences Building Salford Royal NHS Foundation Trust Hospital Stott Lane, Salford Manchester UK M6 8HD

Publisher

Wiley

Subject

Pharmacology (medical)

Reference117 articles.

1. Controlled double-blind trial of dazoxiben and nifedipine in the treatment of Raynaud's phenomenon;Ettinger;American Journal of Medicine,1984

2. Nifedipine in the treatment of Raynaud's phenomenon. Evidence for inhibition of platelet activation;Malamet;American Journal of Medicine,1985

3. Reproducibility of cold provocation in patients with Raynaud's phenomenon;Wigley;Journal of Rheumatology,1987

4. Nicardipine in the treatment of Raynaud's phenomenon;Kahan;Revue du Rhumatisme et des Maladies Osteo-Articulaires,1987

5. Nicardipine in the treatment of Raynaud's phenomenon: A randomized double-blind trial;Kahan;Angiology,1987

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Raynaud’s Phenomenon: A Current Update on Pathogenesis, Diagnostic Workup, and Treatment;Vascular Specialist International;2024-07-23

2. Practical Approach to the Patient with Raynaud’s Phenomenon: Primary Versus Secondary Raynaud’s Phenomenon;Raynaud’s Phenomenon;2024

3. Drug Therapy;Raynaud’s Phenomenon;2024

4. Endothelial Dysfunction in Systemic Sclerosis;International Journal of Molecular Sciences;2023-09-21

5. A Systematic Review of Aminaphtone from Pathophysiology to Clinical Applications: Focus on New Rheumatological Acquisitions;Pharmaceuticals;2023-04-10